ARWR - Company ID 0000879407
The table below shows ARROWHEAD PHARMACEUTICALS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | - | $1.60B | $714.97M | - | - | - |
| Receivables | $8.56M | $15.69M | $218.87M | $9.70M | $2.37M | $2.50M |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.67B |
| $1.84B |
| $1.17B |
| $946.92M |
| $1.14B |
| $570.54M |
| Property, plant & equipment | $373.30M | $374.82M | $378.58M | $381.05M | $384.80M | $387.07M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $2.11B | $2.27B | $1.60B | $1.38B | $1.57B | $1.01B |
| Accounts payable | $27.78M | $30.75M | $32.94M | $33.05M | $9.98M | $14.46M |
| Total current liabilities | $283.35M | $295.22M | $347.43M | $194.53M | $220.54M | $93.76M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$1.92B | -$1.73B | -$1.60B | -$1.60B | -$1.43B | -$1.80B |
| Total equity | $465.53M | $613.98M | $568.42M | $522.31M | $683.32M | $52.59M |